
Dr Rugo on Research Needed to Clarify the Role of T-DXd Plus Pertuzumab in HER2+ Breast Cancer
"Using [T-DXd plus pertuzumab] markedly improved PFS [vs THP]. What we want to know is: How [should we] use this in clinical practice, and for which patients?" Hope S. Rugo, MD, a professor in the Department of Medical Oncology & Therapeutics …